Ryberg

Hospital-acquired infections affect 7–10% of patients and cause over 25 million extra hospital days in Europe every year. The cost: up to €24 billion annually. Manual disinfection is inconsistent, impossible to audit, and leaves dangerous gaps. Ryberg is changing that. We build autonomous UV-C disinfection robots that eliminate 99.99% of pathogens — including C. difficile, MRSA, and VRE — without chemicals, without human error, and with a verified data report after every cycle. Our flagship product, Omnia, combines 360-degree UV-C distribution, autonomous navigation, and intelligent safety features to disinfect hospital rooms, pharmaceutical clean rooms, and biomedical facilities faster and more thoroughly than any manual process. The results speak for themselves: → 30% reduction in C. difficile infections → 44% reduction in viral infections → $1.2 million in annual savings per facility from fewer HAIs Headquartered in Amsterdam with a growing team of roboticists, engineers, and infection prevention experts, Ryberg is trusted by hospitals and distributors across Europe and the Middle East. Ready to see Omnia in action? Visit ryberghealthcare.com to book a demo.